(Q44295947)

English

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods? (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Giovanni Paganelli

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Marco Chinol

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

30 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

773-776

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Combined treatment of advanced oropharyngeal cancer with external radiotherapy and three-step radioimmunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloning and characterization of Scavidin, a fusion protein for the targeted delivery of biotinylated molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in pretargeting biotechnology

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretargeting with the affinity enhancement system for radioimmunotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The avidin-biotin complex in immunology

1 reference

https://pubmed.ncbi.nlm.nih.gov/12557049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-002-1090-0

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44295947&oldid=2206550097"